Literature DB >> 29250293

Hypothetical "anatomy" of Brugada phenomenon: "Long QT sine Long QT" syndrome implicating morphologically undefined specific "Brugada's myocells".

Petras Stirbys1.   

Abstract

The Brugada syndrome (BrS) is associated with increased risk of ventricular arrhythmias and sudden cardiac death. It generates genetically mediated arrhythmias posing a true pathophysiological challenge. In search of the similarities between BrS and long QT syndrome some novel insights are suggested. In patients with BrS the duration of QT interval is usually normal. Some investigators have found prolonged QT interval in the syndrome's natural course or the duration of QT segment have been extended by provocative tests unmasking BrS. Thus, BrS might be characterized as "long QT sine long QT" syndrome. The existence of two functional types of myocites is suspected. Regarding structure and function the majority of ventricular myocardium is probably mostly healthy. The rest of myocardium (preferably the subepicardium of right ventricular outflow tract) due to its genotypic peculiarities demonstrates no negative influence on ventricular performance until early adulthood is reached and/or other unstable preconditions are fulfilled (nocturnal time, fever, specific drugs, etc.). Based on published findings of positive outcomes, following the epicardial ablation of the right ventricular outflow tract region, a new hypothetical concept suggesting the presence of specific, genetically affected "Brugada's myocells" is proposed. These cells as a suitable arrhythmogenic substrate reside intramurally within the subepicardial region of the outflow tract of right ventricle. In the daytime these cells likely are dormant but at rest their nocturnal proarrhythmic behavior is activated occasionally. Presumptions regarding the pathophysiology of BrS might be the focus of further discussion.

Entities:  

Keywords:  Brugada syndrome; Brugada’s myocells; arrhythmogenic substrate; ventricular arrhythmias; “long QT sine long QT” syndrome

Year:  2017        PMID: 29250293      PMCID: PMC5673343          DOI: 10.4022/jafib.1554

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  45 in total

Review 1.  Brugada syndrome.

Authors:  Yuka Mizusawa; Arthur A M Wilde
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-01

Review 2.  Short and long QT syndromes: does QT length really matter?

Authors:  Jean-Philippe Couderc; Coeli M Lopes
Journal:  J Electrocardiol       Date:  2010 Sep-Oct       Impact factor: 1.438

3.  Brugada-type electrocardiographic changes induced by fever.

Authors:  Vishesh Kumar; Neha Patel; Nathan Van Houzen; Neeraj Saini
Journal:  Circulation       Date:  2013-05-28       Impact factor: 29.690

4.  Brugada syndrome: update 2009.

Authors:  Pedro Brugada; Begoña Benito; Ramon Brugada; Josep Brugada
Journal:  Hellenic J Cardiol       Date:  2009 Sep-Oct

Review 5.  Brugada syndrome: a decade of progress.

Authors:  C Antzelevitch; P Brugada; J Brugada; R Brugada; W Shimizu; I Gussak; A R Perez Riera
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

6.  Challenging the unifying pathophysiological concept of J-wave syndromes.

Authors:  Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-04-27       Impact factor: 6.343

7.  Electrophysiologic precursors of ventricular tachyarrhythmias.

Authors:  J Han; B G Goel
Journal:  Arch Intern Med       Date:  1972-05

8.  The regulation of heart rate during sleep.

Authors:  W Baust; B Bohnert
Journal:  Exp Brain Res       Date:  1969       Impact factor: 1.972

Review 9.  Brugada syndrome.

Authors:  Jessica Jellins; Mitchell Milanovic; David-Joel Taitz; S H Wan; P W Yam
Journal:  Hong Kong Med J       Date:  2013-04       Impact factor: 2.227

10.  Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone.

Authors:  N El-Sherif; B J Scherlag; R Lazzara; R R Hope
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.